Avastin — Class II drug recall D-918-2013
Terminated recall by Clinical Specialties Compounding Pharmacy, reported 2013-09-04, distributed in FL, GA, IN, LA, SC. Lack of Assurance of Sterility; product linked to adverse event reports of endophthalimitis eye infections and
| Recall number | D-918-2013 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Clinical Specialties Compounding Pharmacy, Augusta, GA, United States |
| Recall initiated | 2013-03-11 |
| Classified | 2013-08-23 |
| Reported by FDA | 2013-09-04 |
| Terminated | 2017-02-22 |
| Distributed | FL, GA, IN, LA, SC |
| Quantity | 2,190 syringes |
| Reason classes | sterility |
| Expiration dates | 2013-02-24, 2013-03-01, 2013-03-16, 2013-03-19, 2013-03-23, 2013-03-26, 2013-03-27, 2013-03-29, 2013-03-31, 2013-04-01, 2013-04-02, 2013-04-03, 2013-04-04, 2013-04-07, 2013-04-08, 2013-04-09, 2013-04-10, 2013-04-13, 2013-04-14, 2013-04-15, 2013-04-16, 2013-04-17, 2013-04-19, 2013-04-21, 2013-04-22 and 24 more |
Product
Avastin, (0.05 ml, 1.25 mg/0.05ml), single unit dose syringes, Clinical Specialties Compounding Pharmacy, Augusta, GA
Reason for recall
Lack of Assurance of Sterility; product linked to adverse event reports of endophthalimitis eye infections and FDA inspection findings resulted in concerns regarding quality control processes
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-918-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.